Neo Ivy Capital Management Acadia Pharmaceuticals Inc Transaction History

Neo Ivy Capital Management

$294 Million
Q3 2024

A detailed history of Neo Ivy Capital Management transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Neo Ivy Capital Management holds 3,482 shares of ACAD stock, worth $57,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,482

Previous 203,048 98.29%

Holding current value

$57,000

Previous $3.3 Million 98.39%

% of portfolio

0.02%

Previous 0.65%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$15.14 - $19.14 $3.02 Million - $3.82 Million	-199,566 Reduced 98.29%	3,482 $53,000
Q2 2024 Jul 19, 2024	BUY	$14.62 - $18.42 $2.97 Million - $3.74 Million	203,045 Added 6768166.5%	203,048 $3.3 Million
Q4 2023 Feb 23, 2024	BUY	$20.78 - $31.77 $62 - $95	3 New	3 $0
Q2 2023 Aug 15, 2023	BUY	$17.8 - $25.65 $649,397 - $935,788	36,483 New	36,483 $873,000
Q2 2022 Aug 16, 2022	SELL	$13.01 - $27.22 $16,392 - $34,297	-1,260 Reduced 79.55%	324 $4,000
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $35,221 - $46,255	-1,682 Reduced 51.5%	1,584 $38,000
Q4 2021 Feb 15, 2022	BUY	$16.79 - $27.09 $54,836 - $88,475	3,266 New	3,266 $0
Q3 2021 Nov 16, 2021	SELL	$15.78 - $24.77 $3,976 - $6,242	-252 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $116,516 - $164,684	-6,006 Reduced 95.97%	252 $6,000
Q1 2021 Oct 07, 2021	BUY	$25.02 - $54.99 $49,514 - $108,825	1,979 Added 46.25%	6,258 $161,000
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $44,569 - $61,673	1,086 Added 34.01%	4,279 $229,000
Q3 2020 Nov 17, 2020	SELL	$36.42 - $57.0 $496,732 - $777,423	-13,639 Reduced 81.03%	3,193 $131,000
Q2 2020 Aug 17, 2020	BUY	$39.26 - $52.73 $399,313 - $536,316	10,171 Added 152.69%	16,832 $0
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $210,820 - $312,201	6,661 New	6,661 $281,000
Q3 2019 Nov 21, 2019	SELL	$22.22 - $44.01 $374,007 - $740,776	-16,832 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$23.32 - $28.12 $335,598 - $404,674	14,391 Added 589.55%	16,832 $450,000
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $39,470 - $66,834	2,441 New	2,441 $65,000

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.

Account

Neo Ivy Capital Management Acadia Pharmaceuticals Inc Transaction History